Sildenafil citrate on nitrergic transmission in anococcygeus muscles from the urogenital system of male and female mice

By Frith D.   Gibson A.  

European Journal of Pharmacology, Vol. 400, Iss. 2, 2000-07 ,pp. : 305-312

Elsevier

Access to resources Recommend Favorite

Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta

By Mochida H.   Inoue H.   Takagi M.   Noto T.   Yano K.   Kikkawa K.  

European Journal of Pharmacology, Vol. 440, Iss. 1, 2002-04 ,pp. : 45-52

Elsevier

Access to resources Recommend Favorite

The ability of phosphodiesterase-5 inhibitors sildenafil and ordonafil to reverse L-NAME induced cardiac hypertrophy in the rabbit: possible role of calcineurin and p38

By Siam Aiad   Al Kaabba Abdulaziz   Mohammad Mukhallad   Khatib Said  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-09 ,pp. : 1247-1255

NRC Research Press

Access to resources Recommend Favorite

ADMET considerations for phosphodiesterase-5 inhibitors

By Rezvanfar Mohammad Amin   Rahimi Hamid Reza   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1231-1245

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Effects of Phosphodiesterase 5 Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3485-3494

Bentham Science Publishers

Access to resources Recommend Favorite